allogeneic crispr-cas9 engineered anti-cd19 car t-cells ctx112

Generic: Allogeneic CRISPR-Cas9 Engineered Anti-CD19 CAR T-cells CTX112

Get deeper analysis on allogeneic crispr-cas9 engineered anti-cd19 car t-cells ctx112

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    allogeneic crispr-cas9 engineered anti-cd19 car t-cells ctx112 — Drug Pipeline, Trials & FDA Status | BioSniper